QQ客服 官方微博 反馈留言

	BRAF and EGFR inhibitors synergize to increase cytotoxic effects and decrease stem cell capacities in BRAF(V600E)-mutant colorectal cancer cells
	Wu, Zhenhua; Huang, Mingzhu; Gong, Yiwei; Lin, Chen; Guo, Weijian
刊名	ACTA BIOCHIMICA ET BIOPHYSICA SINICA
	2018
卷号	50期号:4
关键词	BRAF inhibitor dabrafenib cetuximab colorectal cancer cancer stem cells
ISSN号	1672-9145
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3607376
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Wu, Zhenhua,Huang, Mingzhu,Gong, Yiwei,et al. BRAF and EGFR inhibitors synergize to increase cytotoxic effects and decrease stem cell capacities in BRAF(V600E)-mutant colorectal cancer cells[J]. ACTA BIOCHIMICA ET BIOPHYSICA SINICA,2018,50(4).
APA	Wu, Zhenhua,Huang, Mingzhu,Gong, Yiwei,Lin, Chen,&Guo, Weijian.(2018).BRAF and EGFR inhibitors synergize to increase cytotoxic effects and decrease stem cell capacities in BRAF(V600E)-mutant colorectal cancer cells.ACTA BIOCHIMICA ET BIOPHYSICA SINICA,50(4).
MLA	Wu, Zhenhua,et al."BRAF and EGFR inhibitors synergize to increase cytotoxic effects and decrease stem cell capacities in BRAF(V600E)-mutant colorectal cancer cells".ACTA BIOCHIMICA ET BIOPHYSICA SINICA 50.4(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。